Related references
Note: Only part of the references are listed.Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo
Mingshuang Sun et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations
Zongrui Zhang et al.
DRUG DELIVERY (2018)
The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways
Congxiang Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Improvement of chemosensitivity and inhibition of migration via targeting tumor epithelial-to-mesenchymal transition cells by ADH-1-modified liposomes
Zhaoming Guo et al.
DRUG DELIVERY (2018)
Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
Guido Giordano et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery
Qiang Fu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Epidemiology of Lung Cancer
Yousheng Mao et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma
Vikas Pandey et al.
DRUG DELIVERY (2015)
Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery
Daquan Chen et al.
DRUG DELIVERY (2014)
Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo
Cuiyan Han et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2014)
Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer
Michael E. Werner et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1
Kholoud Arafat et al.
PLOS ONE (2013)
Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis
Leyre Larzabal et al.
PLOS ONE (2013)
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
Cord Naujokat et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
In Vivo Induction of Apoptosis by Fucoxanthin, a Marine Carotenoid, Associated with Down-Regulating STAT3/EGFR Signaling in Sarcoma 180 (S180) Xenografts-Bearing Mice
Jun Wang et al.
MARINE DRUGS (2012)
Identification and quantification of salinomycin in intoxicated human plasma by liquid chromatography-electrospray tandem mass spectrometry
Yu Li et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
Nikolaos A. Dallas et al.
CANCER RESEARCH (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
H Gelderblom et al.
EUROPEAN JOURNAL OF CANCER (2001)
Role of formulation vehicles in taxane pharmacology
L van Zuylen et al.
INVESTIGATIONAL NEW DRUGS (2001)
Share Paper
